The purpose of this tool is to allow cancer services to review the uptake of clinical governance roles and responsibilities by their medical oncologists, haematologists, nurses, pharmacists and managers working in its cancer care areas.
The Commission has negotiated with Regulators and Accrediting Agencies the process of health service organisations applying for actions to be non applicable and verifying applications. Two mechanisms exist for conferring not applicable actions
Quality Use of Medicines and Medicines Safety was made the 10th National Health Priority Area in 2019 by the Council of Australian Governments (COAG) Health Council. This discussion paper has been developed to support public consultation for the national baseline report on Quality Use of Medicines and Medicines Safety. Phase 1 of the report focuses on polypharmacy, use of antipsychotic medicines and transitions of care in the aged care setting.